Genome Valley (GV), the first of its kind in India, is a state-of-the-art life sciences cluster housing over 200 life science companies. With its conducive ecosystem for research and innovation, GV has become an attractive destination for scientists and researchers worldwide.
Over the years, GV has evolved into a thriving ecosystem not only for vaccine, biotechnology, and pharmaceutical companies but also for full-service Contract Research Organizations (CROs) & Contract Development and Manufacturing Organizations (CDMOs), earning its reputation as Asia’s premier life sciences hub.
Located strategically in Hyderabad, known as the ‘Pharma Capital of India’, GV offers seamless access to a vast pharmaceutical and biotech network. This strategic location, combined with support from both the government and private sector, has propelled GV to the forefront of preclinical research in Asia.
This remarkable transformation is fueled by a combination of cutting-edge research, state-of-the-art infrastructure, a skilled talent pool, and strategic collaborations.